Research Focus: MEN-2B treatment outcomes and letrozole for delayed puberty

2019-09-16T12:09:32+00:00April 1st, 2019|Paediatric endocrinology, Podcast|

In our first edition, Professor Frederic Castinetti discussing the results of an international collaboration to study the natural history and treatment outcomes of multiple endocrine neoplasia type 2B, and Professor Martin Savage comments on a randomized trial of letrozole versus testosterone in boys with constitutional delay of growth and puberty.